Research & Development



  從頭到尾都沒有再提交還弩弓的事情。   而且開國的時候建都櫟陽,秦陵這才逐漸退出了野心家們的視野。亚洲伊人色综网   雲瑯沒有問是誰打的,只知道太宰這條船似乎不是很安穩。亚洲国模私拍人体gogo   靠猜想來認字的最大缺點就是得出來的結論大多數為胡說八道。   太宰哼了一聲之後就重新躺在了床上。亚洲无码   “咱們是大秦的士,在漢國估計會被砍頭吧?”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo